CANNAPHARMARX, INC.

CPMD ·Healthcare, Drug Manufacturers - General
Financial Statements SEC Filings

SEC Filings

Form Filed Description
EFFECT May 4, 2021
POS AM May 3, 2021 POS AM
CORRESP Apr 28, 2021
UPLOAD Apr 23, 2021
POS AM Apr 21, 2021 POS AM 2
CORRESP Apr 21, 2021
UPLOAD Apr 20, 2021
POS AM Apr 15, 2021 POST EFFECTIVE AMENDMENT NO. 1
10-K Apr 14, 2021 ANNUAL REPORT
NT 10-K Apr 1, 2021 10-K EXTENSION
8-K Jan 28, 2021 FORM 8-K
EFFECT Jan 25, 2021
8-K Jan 22, 2021 FORM 8-K
424B3 Jan 20, 2021 PROSPECTUS
CORRESP Jan 19, 2021
S-1/A Jan 15, 2021 FORM S-1 AMENDMENT
8-K Jan 12, 2021 FORM 8-K
CORRESP Dec 18, 2020
S-1/A Dec 18, 2020 FORM S-1 AMENDMENT 1
UPLOAD Dec 15, 2020
DEL AM Dec 2, 2020 DELAY REQUEST
S-1 Nov 27, 2020 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
10-Q Nov 12, 2020 FORM 10-Q
8-K Aug 20, 2020 FORM 8-K
10-Q Aug 19, 2020 FORM 10-Q
← Newer Page 4 of 14 · 338 filings Older →